Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / TWST - Centogene gets CE marking in EU for cloud-based software platform

TWST - Centogene gets CE marking in EU for cloud-based software platform

Twist Bioscience Corporation
German biotech, Centogene (NASDAQ:CNTG) announced on Wednesday that its CentoCloud cloud-based Software as a Service ((SaaS)) platform for clinical decision making is now CE-marked in Europe under the In Vitro Diagnostics Directive. Europe's new In Vitro Diagnostic Regulation takes effect tomorrow. CE-marking is required for all IVD devices sold in the European Economic Area (EEA) countries, as well as Iceland, Norway, and Liechtenstein. As a CE-marked device, CentoCloud will be made available in the region for clinical diagnosis of patients with genetic diseases, the company said. Read: In January, Centogene (CNTG) announced the global launch of CentoCloud, which is also designed to use the reagent kits the company is developing with U.S.-based biotech Twist Bioscience (TWST) for rare disease diagnostics.

For further details see:

Centogene gets CE marking in EU for cloud-based software platform
Stock Information
Company Name: Twist Bioscience Corporation
Stock Symbol: TWST
Market: NASDAQ
Website: twistbioscience.com
Menu
TWST TWST Quote TWST Short TWST News TWST Articles TWST Message Board
Get TWST Alerts

News, Short Squeeze, Breakout and More Instantly...